Compound Profile

GHK Cu

Copper-binding tripeptide

GHK Cu is a naturally occurring copper binding tripeptide with a genuinely well supported topical cosmetic evidence base — including human RCTs for skin firmness, fine lines, and wound healing — plus a separate, much less evidenced injectable/RUO research peptide use.

Use extra caution Topical GHK Cu has a good safety track record in cosmetic use, with occasional mild irritation reported at higher concentrations. Details

Last reviewed: Report a correctionProfile-wide ·Unassigned
GHK Cu monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Editorial grade not demonstrated by recorded studies
Safety
Topical GHK-Cu has a good safety track record in cosmetic use, with occasional mild irritation reported at higher concentrations.
Profile context
Copper Cofactor Delivery (Lysyl Oxidase and Superoxide Dismutase), Collagen and Elastin Synthesis Stimulation, Antioxidant and Anti-Inflammatory Activity
Next steps

Continue reading

Regulatory status

2026 federal and state regulatory context

Last checked 2026 06 30

Topical cosmetic use is a legitimate, established commercial channel. Injectable/systemic use falls into the same RUO regulatory category as other research peptides.

Regulatory changelog

  • 2026 02: Injectable GHK Cu named among peptides expected to move toward Category 1 compounding status per HHS/FDA announcement. Mid 2026: Formal rulemaking still pending.

Quick stats

Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
Copper Cofactor Delivery (Lysyl Oxidase And Superoxide Dismutase), Collagen And Elastin Synthesis Stimulation, Antioxidant And Anti Inflammatory Activity
Avoid / review if
Wilson's Disease Or Other Copper Metabolism Disorders, Known Copper Allergy Or Hypersensitivity, Pregnancy/Breastfeeding (No Established Safety Data)

Botanical Context

Source botanicals and comparison guides related to GHK Cu.

Safety

Safety & Cautions

Topical GHK Cu has a good safety track record in cosmetic use, with occasional mild irritation reported at higher concentrations. Injectable/systemic GHK Cu safety data in humans is much more limited than the topical literature, and shares the same RUO sourcing and quality control caveats as other gray market peptides.

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Evidence Summary

Profile-wide ·Unassigned

Evidence lens

Treat this profile as unresolved until source review is complete.

Needs reviewNeeds review

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedCopper Cofactor Delivery (Lysyl Oxidase · Superoxide Dismutase) · Collagen And Elastin Synthesis Stimulation

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableTopical GHK Cu has a good safety track record in cosmetic use, with occasional mild irritation reported at higher concentrations.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Needs review

GHK Cu has an evidence rating that is still under review.

Inflammation SupportLongevity
Effects
4
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How GHK Cu Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How GHK Cu Works

How GHK Cu WorksGHK Cu acts on biological target pathways via angiogenesis (modulation), leading to copper cofactor delivery (lysyl oxidase and superoxide dismutase).GHK CuBiological TargetBiological pathwayAngiogenesisModulationCopper Cofactor Delivery (Lysyl Oxidase And Superoxide Dismutase)Observable outcomeAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
No established consumer dosing protocol; see full guide article for regulatory and safety context.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Copper Cofactor Delivery (Lysyl Oxidase
  • Superoxide Dismutase)
  • Collagen And Elastin Synthesis Stimulation
  • Antioxidant And Anti Inflammatory Activity
  • Wound Healing Angiogenesis Support
  • Collagen And Elastin Remodeling

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the GHK Cu evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Sourcing options disabled for safety

Direct product recommendations and affiliate links are suppressed for this compound due to its high caution or needs-review safety classification.

Evaluate the safety checks, contraindications, and potential medication interactions above under clinician supervision before use.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Compound profile context

How to interpret GHK Cu

GHK Cu compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing GHK Cu, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.